Approvals For Long-Pending PMAs Drive Up Average Approval Times In 2004
This article was originally published in The Gray Sheet
Executive Summary
The average elapsed time between submission and FDA approval for original PMAs increased from 350 days in 2003 to 504 in 2004
You may also be interested in...
Premarket Notification “Not Substantially Equivalent” Rates Trending Upward
The rate of 510(k)s found "not substantially equivalent" has been rising over the last four fiscal years, an FDL-1Office of Device Evaluation annual report suggests
Premarket Notification “Not Substantially Equivalent” Rates Trending Upward
The rate of 510(k)s found "not substantially equivalent" has been rising over the last four fiscal years, an FDL-1Office of Device Evaluation annual report suggests
Abbott Consent Decree Costs Escalate With Failed FDA QSR Inspection
Costs related to Abbott's FDA consent decree could approach $1 bil. in lost revenue alone following a failed follow-up inspection of the company's Lake County, Illinois diagnostic manufacturing operations